Publication | Open Access
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
201
Citations
11
References
2020
Year
Once-weekly treatment with insulin icodec had glucose-lowering efficacy and a safety profile similar to those of once-daily insulin glargine U100 in patients with type 2 diabetes. (Funded by Novo Nordisk; NN1436-4383 ClinicalTrials.gov number, NCT03751657.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1